Skip to search formSkip to main contentSkip to account menu

MFECP1

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Conditions for safe and effective ADEPT treatment
Antibody directed enzyme prodrug therapy (ADEPT) is a drug delivery system developed for the treatment of cancer. ADEPT uses a… 
2006
2006
Study of SingleAdministration of Antibody-Directed Enzyme ProdrugTherapy with the Recombinant Anti ^ Carcinoembryonic Antigen Antibody-Enzyme Fusion Protein MFECP 1 and a Bis-Iodo Phenol Mustard…
Purpose: Antibody-directed enzyme prodrug therapy is a two-stage treatment whereby a tumor-targeted antibody-enzyme complex… 
2005
2005
Immunogenicity of a glycosylates antibody-enzyme fusion protien (MFECP1) in a phase I/II clinical study of ADEPT
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)